• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Machine Learning Model Integrates Multimodal Data to Stratify Glioblastoma Survival Risk

by
November 6, 2026
in Health
Reading Time: 3 mins read
0
Machine Learning Model Integrates Multimodal Data to Stratify Glioblastoma Survival Risk

Machine Learning Model Integrates Multimodal Data to Stratify Glioblastoma Survival Risk

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A multimodal machine learning nomogram that integrates clinical, deep learning radiomics, and weakly-supervised pathomics signatures improves overall survival risk stratification in patients with IDH-wildtype glioblastoma, according to an internally validated single-center study. The prognosis for glioblastoma remains dismal, making accurate prognostic stratification crucial for guiding clinical decisions. To address this clinical challenge, researchers established and evaluated the combined multimodal model for individualized survival risk assessment.

The study was conducted using a multimodal dataset comprising 194 consecutively enrolled patients with IDH-wildtype glioblastoma. To evaluate model development and performance, the full patient cohort was split into a training set of 136 patients and a test set of 58 patients using stratified random sampling based on 1-year overall survival status. Feature screening within the training cohort was carried out using LASSO-Cox regression paired with 10-fold cross-validation.

The investigation examined three distinct feature modalities to establish individual prognostic signatures. Clinical features were analyzed using Cox regression to yield a clinical signature model, although these clinical features demonstrated suboptimal performance in prognosis analysis. For imaging data, deep learning neural networks—specifically ResNet101, DenseNet121, and Inception_v3—were applied to extract radiomics features, generating a deep learning radiomics signature designated DL-Rad_Sig. In parallel, pathomics features were extracted from hematoxylin and eosin (H&E)-stained whole slide images, producing a pathomics signature designated Path_Sig.

Both the deep learning radiomics and pathomics models achieved effective prognostic stratification for glioblastoma patients, and pathomics features extracted from H&E-stained whole slide images were significantly associated with clinical outcomes. In evaluation metrics, the DL-Rad_Sig model achieved concordance index values of 0.852 in the training cohort and 0.721 in the test cohort. Modeling for the Path_Sig signature utilized six selected pathomics features, resulting in concordance index values of 0.821 in the training cohort and 0.762 in the test cohort.

When researchers evaluated the fusion of clinical, radiomics, and pathomics signatures against each individual signature, the combined nomogram demonstrated superior predictive performance. For overall survival, the integrated model achieved a C-index of 0.887 in the training cohort and 0.791 in the test cohort. Kaplan-Meier survival curves generated for the combined nomogram showed a statistically significant difference in overall survival rates between high-risk and low-risk patient groups. Furthermore, receiver operating characteristic curve analysis of the nomogram for predicting 1-, 2-, and 3-year overall survival produced area under the curve values of 0.871, 0.725, and 0.833, respectively.

While the multimodal fusion nomogram serves as a non-invasive tool for prognostic evaluation, the authors noted several important constraints. The study performed only single-center internal validation without independent external cohorts, and patch-level pathomics models exhibited obvious training-set overfitting requiring cautious interpretation. Consequently, external multi-center validation remains necessary to verify the generalizability of the findings.

Subject of Research: Multimodal machine learning for glioblastoma survival risk stratification

Article Title: Multimodal data integration using machine learning improves prognosis risk stratification of glioblastoma patients

Article References: Zhou, Q., Ke, X., Zhang, B., Zhang, P., Xue, C., Kang, J., Man, J., Zhao, Z., Zhao, J., & Zhou, J. (2026). Multimodal data integration using machine learning improves prognosis risk stratification of glioblastoma patients. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-03014-7

Image Credits: AI Generated

DOI: 10.1186/s12880-026-03014-7

Keywords: glioblastoma, machine learning, radiomics, pathomics, prognostic stratification, deep learning, overall survival, medical imaging, Multimodal, data, integration, machine

News Source: Blake Davidson. (November 6, 2026). Machine Learning Model Integrates Multimodal Data to Stratify Glioblastoma Survival Risk. Scienmag.

Tags: datadeep learningGlioblastomaintegrationmachineMachine LearningMedical Imagingmultimodaloverall survivalpathomicsprognostic stratificationradiomics
Share12Tweet7Share2ShareShareShare1

Related Posts

Cardiac MRI and Ultrasound Strain Measures Differ in Chronic Ischemic Disease

Cardiac MRI and Ultrasound Strain Measures Differ in Chronic Ischemic Disease

November 19, 2026
Mathematical Formulas for Ventilator Energy Show Wide Discrepancies in Intensive Care

Mathematical Formulas for Ventilator Energy Show Wide Discrepancies in Intensive Care

November 19, 2026

Network Meta-Analysis Compares Janus Kinase Inhibitors and Adalimumab in Psoriatic Arthritis

November 19, 2026

Aging Drives Rising Absolute Neurological Disorder Burden Across Western Pacific Nations

November 19, 2026

POPULAR NEWS

  • East Hararghe Farmers Show Mixed Perceptions Toward Irrigated Cluster Wheat Farming

    East Hararghe Farmers Show Mixed Perceptions Toward Irrigated Cluster Wheat Farming

    29 shares
    Share 12 Tweet 7
  • Fruit and Vegetable Consumption Declined Among Iranian Adults With Hypertension Over 15 Years

    29 shares
    Share 12 Tweet 7
  • Multiscale Fusion Dehazing Algorithm Preserves Sharp Edges in Foggy Driving Vision

    29 shares
    Share 12 Tweet 7
  • Periorbital Anthrax Mimicked Necrotizing Infection Following Soil Trauma in Case Report

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cardiac MRI and Ultrasound Strain Measures Differ in Chronic Ischemic Disease

Mathematical Formulas for Ventilator Energy Show Wide Discrepancies in Intensive Care

Network Meta-Analysis Compares Janus Kinase Inhibitors and Adalimumab in Psoriatic Arthritis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.